Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Hologic Inc (HOLX)

73.58   -1.57 (-2.09%) 02-25 11:09
Open: 74.47 Pre. Close: 75.15
High: 75.14 Low: 73.07
Volume: 390,758 Market Cap: 18,959M
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, surgical products, and light-based aesthetic and medical treatment systems for women in the United States and internationally. The company offers Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for acute respiratory ailments. It also provides breast imaging and analytics, such as 2D and 3D mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company offers aesthetic treatment systems, as well as TempSure, a radio frequency energy-sourced platform, which offers non-surgical and surgical aesthetic treatments and procedures. Further, it offers NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Additionally, the company offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 76.516 - 76.94 76.94 - 77.284
Low: 73.491 - 74.095 74.095 - 74.586
Close: 74.263 - 75.158 75.158 - 75.884

Technical analysis

as of: 2021-02-25 10:38:43 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 93.07     One year: 99.28
Support: Support1: 71.08    Support2: 59.14
Resistance: Resistance1: 79.68    Resistance2: 85.00
Pivot: 79.72
Moving Average: MA(5): 74.99     MA(20): 79.93
MA(100): 73.51     MA(250): 61.60
MACD: MACD(12,26): -0.46     Signal(9): 0.63
Stochastic oscillator: %K(14,3): 13.40     %D(3): 13.01
RSI: RSI(14): 38.70
52-week: High: 85.00  Low: 26.49  Change(%): 57.1
Average Vol(K): 3-Month: 193626  10-Days: 223141

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
HOLX has closed above bottom band by 9.7%. Bollinger Bands are 66.2% wider than normal. The large width of the bands suggest high volatility as compared to HOLX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Tue, 23 Feb 2021
Hologic Inc. (HOLX) Rises 1.25% for February 23 - Equities.com

Mon, 22 Feb 2021
Hologic Inc. stock falls Monday, underperforms market - MarketWatch

Mon, 22 Feb 2021
Here's Why You Should Add Hologic (HOLX) to Your Portfolio - Nasdaq

Fri, 19 Feb 2021
Hologic Inc. stock falls Friday, underperforms market - MarketWatch

Fri, 19 Feb 2021
Hologic is down despite Barron’s bullish view - Seeking Alpha

Wed, 17 Feb 2021
Hologic Inc. stock falls Wednesday, underperforms market - MarketWatch

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. (M) 258
Shares Float (M) 256
% Held by Insiders 0.57
% Held by Institutions 96.99
Shares Short (K) 3,650
Shares Short P. Month (K) 4,750

Stock Financials

EPS 5.260
EPS Est This Year 2.010
EPS Est Next Year 2.150
Book Value (p.s.) 12.690
Profit Margin 30.50
Operating Margin 41.74
Return on Assets (ttm) 17.1
Return on Equity (ttm) 49.9
Qtrly Rev. Growth 89.3
Gross Profit (p.s.) 9.742
Sales Per Share 17.620
EBITDA (p.s.) 8.810
Qtrly Earnings Growth 69.50
Operating Cash Flow (M) 1,430
Levered Free Cash Flow (M) 1,190

Stock Valuations

PE Ratio 14.07
PEG Ratio
Price to Book value 5.83
Price to Sales 4.20
Price to Cash Flow 13.34

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.